Renal sympathetic denervation or (RDN) has shown excellent promise in permanently controlling hypertension in an individual. The treatment works by ablating or cutting off activity of the renal sympathetic nerves on the renal arterial walls. Ablation of certain areas on the walls reduces or stops the hyperactivity of the nerves, which reduces release of certain vasoconstrictors that reduce blood flow and increase pressure.
Current RDN devices comprise of a guiding catheter and sheath, a control unit or generator and an imaging system for guiding the catheter towards the target nerves. The catheter is introduced in the body through the groin artery or femoral artery and guided towards the kidneys. The energy source used is either radiofrequency or ultrasound although current approved devices only use radiofrequency. Energy is delivered to the distal region of the renal arteries for both kidneys.
The global renal denervation devices market size was valued at US$ 88.6 million in 2017, and is expected to exhibit a CAGR of 35.5% over the forecast period (2018 – 2026).
To get a Free Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/798
Recent Developments
Major players operating in the global renal denervation devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, the U.S. Food and Drug Administration granted Breakthrough Device Designation for Medtronic Plc’s Symplicity Spyral Renal Denervation System.
Renal Denervation Devices Market: Drivers
Increasing prevalence of treatment-resistant hypertension is expected to propel growth of the global renal denervation devices market over the forecast period. For instance, according to the study, ‘Prevalence of Apparent Treatment-Resistant Hypertension in the United States’, published in the American Heart Association journal Hypertension in February 2019, the prevalence of treatment-resistant hypertension was 17.7% and 19.7% according to the 2008 and 2018 Scientific Statement definitions, respectively, and around 10.3 million adults in the U.S. suffered from treatment-resistant hypertension according to the 2018 Scientific Statement.
Renal Denervation Devices Market: Opportunities
R&D in renal denervation devices is expected to offer lucrative growth opportunities for players in the global renal denervation devices market For instance, in 2019, a multicenter, sham-controlled study of ReCor Medical Paradise System demonstrated a 6.3 mm Hg greater reduction in daytime ambulatory systolic blood pressure at 2 months by endovascular ultrasound renal denervation (RDN) compared with a sham procedure.
To get Industry Research PDF Brochure Here: https://www.coherentmarketinsights.com/insight/request-pdf/798
Market Trends:
Africa is expected to witness significant growth in the global renal denervation devices market, owing to high prevalence of hypertension in the region. For instance, according to the World Health Organization, Africa accounts for the highest number of high blood pressure cases worldwide, affecting around 46% of adults, owing to increasing urbanization and unhealthy lifestyles.
Renal Denervation Devices Market: Restraints
A major factor limiting growth of the global renal denervation devices market is increasing usage of pharmaceutical therapy. For instance, the number of people adopting pharmaceutical therapy increased from 24.0% in 2013 % to 54.4% of the treated patients increasing by 13.9 million in the U.S. in 2017, according to American College of Cardiology /American Heart Association.
Renal Denervation Devices Market: Competitive Landscape
Major players operating in the global renal denervation device market include, Abbott Laboratories, Boston Scientific Corporation, Cardiosonic Ltd, Medtronic Plc., Kona Medical, Inc., Mercator Medsystems, Inc., ReCor Medical Inc., St. Jude Medical, Inc., Terumo Corporation, and Theragenics Corporation.
Renal Denervation Devices Market: Key Developments
Major players operating in the global renal denervation devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in February 2014, Cordis Corporation, a division of Johnson & Johnson, received CE Mark for Renlane renal denervation system.
Renal Denervation Devices Market: Segmentation
By Product Type
- Simplicity Renal Denervation System
- Vessix Renal Denervation System
- EnligHTN
- Paradise Renal Denervation System
- Iberis Renal Sympathetic Denervation System
- Others
By Technology
- Radiofrequency
- Ultrasound
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
To Direct Purchase this Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/798
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- PORTER’s Analysis
- Mergers and Acquisitions
- Reimbursement Scenario
- Regulatory Scenario
- Epidemiology
- Market Dynamics
- Global Renal Denervation Devices Market, By Product Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Simplicity Renal Denervation System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Vessix Renal denervation System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- EnligHTN
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Paradise Renal Denervation System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Iberis Renal sympathetic Denervation System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Renal Denervation Devices Market, By Technology, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Radiofrequency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Renal Denervation Devices Market, By End User, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837